안과용 초음파 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of ophthalmic ultrasound Market

The global ophthalmic ultrasound market size was valued at USD 303.73 million in 2025. The market is projected to grow from USD 325.19 million in 2026 to USD 578.55 million by 2034, exhibiting a CAGR of 7.47% during the forecast period (2026-2034). North America dominated the global ophthalmic ultrasound market with a 42.34% market share in 2025, driven by advanced healthcare infrastructure and rising prevalence of eye disorders.

Ophthalmic ultrasound devices are specialized diagnostic imaging systems that use high-frequency sound waves to visualize internal eye structures such as the retina, vitreous humor, anterior segment, and orbit. These devices are essential for diagnosing conditions such as glaucoma, diabetic retinopathy, macular degeneration, vitreous hemorrhage, and retinal detachment.

Market Drivers

Growing Prevalence of Eye Disorders

The increasing burden of ophthalmic diseases is a primary driver of market growth. According to data published in March 2025, approximately 30.6% of adults globally are expected to suffer from hyperopia by the end of 2025. In America and Europe, hyperopia prevalence is projected to reach 37.2% and 23.1%, respectively, by the end of 2025.

Additionally, the CDC reported in October 2024 that 4.2 million people in the U.S. were living with glaucoma in 2022, including 1.5 million with vision-affecting glaucoma. The increasing patient population is fueling demand for early and accurate diagnostic imaging tools such as ophthalmic ultrasound systems.

Market Restraints

High Cost of Devices and Alternative Technologies

Despite steady growth, the market faces challenges due to the high cost of devices, ranging between USD 5,500 and USD 20,000. This limits adoption in low- and middle-income countries.

Moreover, the availability of alternative imaging technologies such as Optical Coherence Tomography (OCT), fundus imaging, and MRI presents competitive pressure. For instance, in June 2024, NIDEK CO., LTD. launched the RS-1 Glaucoma OCT system, offering advanced diagnostic capabilities, which may reduce reliance on traditional ultrasound systems.

Market Opportunities

Expansion of Healthcare Infrastructure

The opening of new ophthalmic clinics and hospitals is creating significant growth opportunities. In October 2024, Sydney Eye Hospital launched the Gadigal Eye Clinic, and in March 2024, Optegra Eye Clinic opened in England to enhance ophthalmic services.

Awareness initiatives such as Glaucoma Awareness Week (March 8-16, 2025) organized by L.V. Prasad Eye Institute are further supporting early diagnosis, boosting device utilization globally.

Market Trends

Technological Advancements and Portable Devices

A major market trend is the increasing adoption of portable and technologically advanced ultrasound devices. In May 2024, Quantel Medical launched Pocket III, a handheld ultrasound pachymeter, expanding portable diagnostic solutions.

Additionally, the adoption of 3D imaging technology is rising, offering improved visualization and surgical planning capabilities. Companies such as Sonomed Escalon are introducing integrated 3D ultrasound systems to enhance diagnostic precision.

Segmentation Analysis

By Product

The device segment dominates the market due to increasing product launches and technological advancements. Accessories are also growing steadily due to increased usage during ophthalmic surgeries.

By Device Type

The portable segment is expected to witness the highest growth due to convenience, accessibility, and cost-effectiveness. Cart-based systems continue to grow in hospital settings, while hand-held devices are gaining popularity for outpatient care.

By Imaging Type

The 3D imaging segment is projected to grow at the highest CAGR through 2034, driven by enhanced visualization and improved diagnostic outcomes. The 2D imaging segment continues to hold a significant share due to affordability and widespread use.

By End-user

Ophthalmic clinics are expected to grow at the highest CAGR due to increasing clinic openings. Hospitals remain a major segment due to the high volume of diagnostic procedures.

Regional Insights

North America

North America generated USD 128.59 million in 2025 and held a 42.34% market share. The region benefits from advanced healthcare systems and high awareness levels.

Europe

Europe represents the second-largest market, supported by expanding ophthalmology clinics and strong healthcare funding.

Asia Pacific

Asia Pacific is projected to grow at the highest CAGR through 2034 due to increasing regulatory approvals and healthcare investments. In May 2024, ArcScan Insight 100 received NMPA approval in China, strengthening regional growth.

Latin America & Middle East & Africa

These regions are expected to grow steadily due to increasing awareness campaigns and rising ocular disease prevalence.

Competitive Landscape

Key players operating in the global ophthalmic ultrasound market include:

• Keeler (U.K.)
• HAI Laboratories, Inc. (U.S.)
• Micro Medical Devices (MMD), Inc. (U.S.)
• Lumibird Medical (France)
• NIDEK CO., LTD. (Japan)
• Sonomed Escalon (U.S.)
• DGH Technology, Inc. (U.S.)

Companies are focusing on partnerships, facility expansions, and product innovations. For instance, in February 2025, Keeler launched a new manufacturing facility in Shanghai, China, expanding its global footprint.

Conclusion

The global ophthalmic ultrasound market, valued at USD 303.73 million in 2025, is set to reach USD 578.55 million by 2034, growing at a CAGR of 7.47%. Growth is primarily driven by the rising prevalence of eye disorders, technological advancements, increasing healthcare infrastructure, and expanding awareness initiatives. While high device costs and alternative diagnostic technologies pose challenges, ongoing innovation, portable device adoption, and regional expansion strategies are expected to sustain steady market growth through 2034.

Segmentation By Product

• Device
• Accessories

By Device Type

• Cart-based
• Portable
• Hand-held

By Imaging Type

• 2D Imaging
• 3D Imaging

By End-user

• Hospitals
• Ophthalmic Clinics
• Others

By Region

• North America (By Product, By Device Type, By Imaging Type, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Product, By Device Type, By Imaging Type, By End-user, and By Country/sub-region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product, By Device Type, By Imaging Type, By End-user, and By Country/sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product, By Device Type, By Imaging Type, By End-user, and By Country/sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, By Device Type, By Imaging Type, By End-user, and By Country/sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Ophthalmic Diseases, by Key Countries/Sub-region, 2025
• 4.2. New Product Launches, by Key Players
• 4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)

5. Global Ophthalmic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Device
  • 5.1.2. Accessories
• 5.2. Market Analysis, Insights and Forecast - By Device Type
  • 5.2.1. Cart-based
  • 5.2.2. Portable
  • 5.2.3. Hand-held
• 5.3. Market Analysis, Insights and Forecast - By Imaging Type
  • 5.3.1. 2D Imaging
  • 5.3.2. 3D Imaging
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Hospitals
  • 5.4.2. Ophthalmic Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Ophthalmic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Device
  • 6.1.2. Accessories
• 6.2. Market Analysis, Insights and Forecast - By Device Type
  • 6.2.1. Cart-based
  • 6.2.2. Portable
  • 6.2.3. Hand-held
• 6.3. Market Analysis, Insights and Forecast - By Imaging Type
  • 6.3.1. 2D Imaging
  • 6.3.2. 3D Imaging
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Hospitals
  • 6.4.2. Ophthalmic Clinics
  • 6.4.3. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Ophthalmic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Device
  • 7.1.2. Accessories
• 7.2. Market Analysis, Insights and Forecast - By Device Type
  • 7.2.1. Cart-based
  • 7.2.2. Portable
  • 7.2.3. Hand-held
• 7.3. Market Analysis, Insights and Forecast - By Imaging Type
  • 7.3.1. 2D Imaging
  • 7.3.2. 3D Imaging
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Hospitals
  • 7.4.2. Ophthalmic Clinics
  • 7.4.3. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Ophthalmic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Device
  • 8.1.2. Accessories
• 8.2. Market Analysis, Insights and Forecast - By Device Type
  • 8.2.1. Cart-based
  • 8.2.2. Portable
  • 8.2.3. Hand-held
• 8.3. Market Analysis, Insights and Forecast - By Imaging Type
  • 8.3.1. 2D Imaging
  • 8.3.2. 3D Imaging
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Hospitals
  • 8.4.2. Ophthalmic Clinics
  • 8.4.3. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Ophthalmic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Device
  • 9.1.2. Accessories
• 9.2. Market Analysis, Insights and Forecast - By Device Type
  • 9.2.1. Cart-based
  • 9.2.2. Portable
  • 9.2.3. Hand-held
• 9.3. Market Analysis, Insights and Forecast - By Imaging Type
  • 9.3.1. 2D Imaging
  • 9.3.2. 3D Imaging
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Hospitals
  • 9.4.2. Ophthalmic Clinics
  • 9.4.3. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Ophthalmic Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Device
  • 10.1.2. Accessories
• 10.2. Market Analysis, Insights and Forecast - By Device Type
  • 10.2.1. Cart-based
  • 10.2.2. Portable
  • 10.2.3. Hand-held
• 10.3. Market Analysis, Insights and Forecast - By Imaging Type
  • 10.3.1. 2D Imaging
  • 10.3.2. 3D Imaging
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Hospitals
  • 10.4.2. Ophthalmic Clinics
  • 10.4.3. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Keeler
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. HAI Laboratories, Inc.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Micro Medical Devices (MMD), Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Lumibird Medical
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. NIDEK CO., LTD.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Sonomed Escalon
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. DGH Technology, Inc.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)